SCHEMBL4112658

SCHEMBL4112658

CCOC(=O)c1c(OCC)nn2c(-c3ccc(F)cc3)c(-c3ccccc3Cl)cnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 4/20 0.43
KMT2A Q03164 3/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 1/20 0.43
NPSR1 Q6W5P4 3/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 1/20 0.40
RXFP1 Q9HBX9 2/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 3/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.39
PDE4B Q07343 1/20 0.39
TSHR P16473 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4121612 0.91 PDE10A (0.38) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL4114844 0.88 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL4128916 0.86 LMNA (0.51) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL2085969 0.86 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL4124701 0.85 TP53 (0.43) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL2084104 0.84 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL4109766 0.83 KDM4E (0.50) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL4108806 0.82 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDKMT2AGAA
SCHEMBL2086776 0.82 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL2087297 0.81 GPR119 (0.46) ALDH1A1KDM4EHPGDGAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed
EP-1945220-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CANNABINOID RECEPTOR ANTAGONISTS Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-23 EP disclosed
WO-2007046548-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CANNABINOID RECEPTOR ANTAGONISTS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds RECQL, QTRT1, DPYD ALDH1A1 467/4885KDM4E 2108/4885HPGD 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.